The study of Ruggeri et al. [21] addressed the carriership of FVL mutation and venous thromboembolism (VTE) in 300 patients with PV and ET. The authors found that the prevalence of the FVL mutation in patients with PV and ET was comparable with that in the general population. This evidence concerns the gene F5 and venous thromboembolism.